Daily as of 3 Nov 16:00 ET
- Price
- between the two $17.44 vs 50 $18.43 / 200 $15.10
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 12 Sep 2025 · projected 11 bars out
RLAY | Relay TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$17.44
+$0.16 (+0.93%)
Relay Therapeutics (RLAY) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $18.35 vs 50 $13.75 / 200 $9.50
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 13 Jul 2026 · projected 24 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $17.78 vs 50 $18.11 / 200 $18.61
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 19 Oct 2026 bar 1 · projected 18 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | 💀Death | 4-hour | 18 bars out | 2 bar cross test |
| week of 13 Jul 2026 | 🟨Golden steep | weekly | 24 bars out | Not tested |
| 12 Sep 2025 | 🟨Golden moderate | daily | 11 bars out | Not tested |
| 27 Jun 2025 | 🟨Golden | 4-hour | 13 bars out | — |
| 14 Oct 2024 | 💀Death | 4-hour | 29 bars out | — |
About RLAY
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$50.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid